Date | Product | Disease | Phase | Company | Therapeutic area |
---|---|---|---|---|---|
2011-03-09 | Ery-asp®/Graspa® (eryaspase - L-asparaginase loaded erythrocytes) | acute lymphoblastic leukaemia (ALL) |
2 | Erytech Pharma (France) | Cancer - Oncology |
2011-03-04 | inhaled Bimosiamose | chronic obstructive pulmonary disease (COPD) |
2 | Revotar (Germany) | Respiratory diseases |
2011-03-02 | AGN-214868 (senrebotase) | 2 | Allergan (USA) Syntaxin (UK) | CNS diseases - Urology | |
2011-03-01 | CYT107 (recombinant interleukin-7) | chronically HIV infected persons |
2a | Cytheris (France) | Infectious diseases |
2011-02-28 | Vidofludimus (4SC-101) | inflammatory bowel disease | 2a | 4SC (Germany) | Inflammatory diseases |
2011-02-24 | TRO40303 | acute myocardial infarction | 1 | Trophos (France) | Cardiovascular diseases |
2011-02-23 | APR-246 | refractory hematological malignancies |
1-2 | Aprea (Sweden) | Cancer - Oncology |
2011-02-22 | simeprevir (TMC435) | hepatitis C virus (HCV) genotype-1 | 2b | Medivir (Sweden) Tibotec (J&J group - USA) | Infectious diseases |
2011-02-22 | blood-based biomarker RA-INF-Dx | rheumatoid arthritis | TcLand Expression (France) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases | |
2011-02-22 | RPL554 | mild asthma | Verona Pharma (UK) | Allergic diseases - Inflammatory diseases - Respiratory diseases | |
2011-02-21 | IPP-204106 | cancer | 1-2a | Immupharma (UK) | Cancer - Oncology |
2011-02-21 | cell culture-derived, pediatric vaccine to prevent Japanese Encephalitis | Japanese Encephalitis | 2-3 | Intercell (Austria) | Infectious diseases |
2011-02-18 | eliglustat tartrate | Gaucher's disease |
2 | Genzyme (USA - MA), a Sanofi company (France) | Rare diseases - Genetic diseases |
2011-02-16 | APD421 (intravenous formulation of a currently marketed dopamine D2 antagonist for the new use of prevention and treatment of nausea & vomiting.) | chemotherapy-induced nausea & vomiting (CINV) and post-operative nausea and vomiting (PONV) | 2a | Acacia Pharma (UK) | Cancer - Oncology - CNS diseases |
2011-02-11 | Juvista® (avotermin - human recombinant Transforming Growth Factor Beta3 [TGFBeta3]) | type 1 diabetes | 3 | Renovo (UK) | Metabolic diseases |
2011-02-10 | TMC649128 | chronic hepatitis C virus infection | 1a | Medivir (Sweden) | Infectious diseases |
2011-02-08 | Sitavir® (acyclovir Lauriad™) | herpes labialis |
epidemiological study | BioAlliance Pharma (France) | Infectious diseases |
2011-02-08 | Avastin® (bevacizumab) | reduction of cancer pain | 3 | Roche (Switzerland) | Cancer - Oncology - CNS diseases |
2011-02-07 | THR-100 (Staphylokinase) | acute myocardial infarction | 3 | ThromboGenics (Belgium) Bharat Biotech International (India) | Cardiovascular diseases |
2011-02-07 | zibotentan | non-metastatic castrate resistant prostate cancer (CRPC) | 3 | AstraZeneca (UK) | Cancer - Oncology |